The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analysts said.

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

A single blood draw that can screen for dozens of cancers at once is moving closer to reality in the United States. The Food ...

Freenome, an early cancer detection company developing blood-based screening tests, today announced favorable results from its pivotal clinical validation study assessing the performance of assay and ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

Genital human papillomavirus is the most common sexually transmitted infection in the United States and is thought to be responsible for more than 99% of cervical cancers. HPV screening usually ...

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

Screening mammograms saves lives, and consistency counts for a lot. That's the main message from a new study that looked at how regularly women received mammograms before a breast cancer diagnosis.

Hearing tests can be classified into two main types: diagnostic and screening. Screening tests that employ pure tone audiometry via basic air conduction are utilized to rapidly assess whether more ...